{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:26:17Z","timestamp":1762673177751,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1053\/jinf.2000.0772","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:56:27Z","timestamp":1032429387000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Twice-weekly Pyrimethamine\u2013sulfadoxine Effectively Prevents Pneumocystis carinii Pneumonia Relapse and Toxoplasmic Encephalitis in Patients with AIDS"],"prefix":"10.1016","volume":"42","author":[{"given":"D.","family":"Sch\u00fcrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Behnsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"W\u00fcnsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"volume":"46","journal-title":"MMWR Morb Mortal Wkly Rep","year":"1997","key":"10.1053\/jinf.2000.0772_RF1"},{"key":"10.1053\/jinf.2000.0772_RF2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis ofPneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome","volume":"327","author":"Hardy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/jinf.2000.0772_RF3","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJM199812243392604","article-title":"Atovaquone compared with dapsone for the prevention of Pneumocystis carinii Pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both","volume":"339","author":"El-Sadr","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jinf.2000.0772_RF4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00042560-199706010-00002","article-title":"Meta-analysis of prophylactic treatment against Pneumocystis carinii pneumonia andtoxoplasma encephalitis in HIV-infected patients","volume":"15","author":"Bucher","year":"1997","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/jinf.2000.0772_RF6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(84)90560-9","article-title":"Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine\u2013sulfadoxine","volume":"2","author":"Gottlieb","year":"1984","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0772_RF7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01964427","article-title":"Efficacy of pyrimethamine\/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients","volume":"12","author":"Ruf","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/clinids\/19.1.218","article-title":"Pyrimethamine\/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus","volume":"19","author":"Jurado","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/clinids\/20.3.730","article-title":"Administration of pyrimethamine\/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS","volume":"20","author":"Bessesen","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0753-3322(97)82322-0","article-title":"A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS","volume":"51","author":"Payen","year":"1997","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/jinf.2000.0772_RF11","first-page":"218","article-title":"Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii pneumonia and Toxoplasma encephalitis","volume":"19","author":"Teira","year":"1999","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1053\/jinf.2000.0772_RF12","first-page":"89","article-title":"Toxoplasmosis","author":"Remington","year":"1989"},{"key":"10.1053\/jinf.2000.0772_RF13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01964466","article-title":"Clindamycin\/primaquine versus trimethoprim\/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia","volume":"10","author":"Ruf","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","article-title":"Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine","volume":"116","author":"Dannemann","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF16","first-page":"(RR-17)","volume":"14","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/jinf.2000.0772_RF17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinids\/14.5.1005","article-title":"Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus","volume":"14","author":"Kovacs","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-117-2-163","article-title":"Prophylaxis for toxoplasmosis in AIDS","volume":"117","author":"Beamon","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002030-199404000-00010","article-title":"Toxoplasma gondii infection in advanced HIV infection","volume":"8","author":"Oksenhendler","year":"1994","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0772_RF20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF00211438","article-title":"Risk factors for severe disease due to Toxoplasma gondii in HIV-positive patients","volume":"9","author":"Stellbrink","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"10.1053\/jinf.2000.0772_RF21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0344-0338(11)80331-6","article-title":"Extracerebral toxoplasmosis in AIDS. Histological and immunohistological findings based on 80 autopsy cases","volume":"189","author":"Jautzke","year":"1993","journal-title":"Path Res Pract"},{"key":"10.1053\/jinf.2000.0772_RF22","first-page":"(RR-8)","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/jinf.2000.0772_RF23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial","volume":"317","author":"Fischl","year":"1987","journal-title":"N Eng J Med"},{"key":"10.1053\/jinf.2000.0772_RF24","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.1989.03430170067030","article-title":"Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex","volume":"262","author":"Fischl","year":"1989","journal-title":"JAMA"},{"key":"10.1053\/jinf.2000.0772_RF25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(96)05387-1","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0772_RF26","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/AAC.35.9.1705","article-title":"Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients","volume":"35","author":"Stein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/jinf.2000.0772_RF27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0140-6736(91)93402-U","article-title":"Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease","volume":"337","author":"Ruskin","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0772_RF28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00002030-199202000-00004","article-title":"Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis againstPneumocystis carinii pneumonia in patients with AIDS","volume":"6","author":"Carr","year":"1992","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0772_RF29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/clinids\/20.3.531","article-title":"Once-weekly administration of dapsone\/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis forPneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients","volume":"20","author":"Opravil","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF30","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/00002030-199011000-00015","article-title":"Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex","volume":"4","author":"Kemper","year":"1990","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0772_RF31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00002030-199210000-00017","article-title":"Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity","volume":"6","author":"Slavin","year":"1992","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0772_RF32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0002-9343(93)90352-P","article-title":"Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis","volume":"95","author":"Torres","year":"1993","journal-title":"Am J Med"},{"key":"10.1053\/jinf.2000.0772_RF33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-117-2-106","article-title":"Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS","volume":"117","author":"Carr","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-122-10-199505150-00004","article-title":"Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with HIV","volume":"122","author":"Podzamczer","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00002030-199512000-00007","article-title":"Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis","volume":"9","author":"Antinori","year":"1995","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0772_RF36","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199305273282102","article-title":"Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection","volume":"328","author":"Girard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/jinf.2000.0772_RF37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-105-4-629_1","article-title":"Fansidar prophylaxis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","author":"Fischl","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF38","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/170.4.912","article-title":"Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death","volume":"170","author":"Safrin","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(85)91811-2","article-title":"Adverse reactions to pyrimethamine-sulfadoxine in context of AIDS","volume":"1","author":"Gottlieb","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0772_RF40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/00365549709035901","article-title":"The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia","volume":"29","author":"Teira","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/jinf.2000.0772_RF41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4269\/ajtmh.1998.59.813","article-title":"Efficacy of sulfadoxine-pyrimethamine for the prevention of placental malaria in an areaof Kenya with a high prevalence of malaria and human immunodeficiency virus infection","volume":"59","author":"Parise","year":"1998","journal-title":"Am Trop Med Hyg"},{"key":"10.1053\/jinf.2000.0772_RF42","first-page":"571","volume":"37","year":"1988","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1053\/jinf.2000.0772_RF43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4269\/ajtmh.1986.35.451","article-title":"Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar\u00ae) for malaria prophylaxis","volume":"35","author":"Miller","year":"1986","journal-title":"Am J Trop Med"},{"key":"10.1053\/jinf.2000.0772_RF44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2165\/00002018-199308020-00006","article-title":"How frequent are notified severe cutaneous adverse reactions to Fansidar\u00ae","volume":"8","author":"St\u00fcchler","year":"1993","journal-title":"Drug Safety"},{"key":"10.1053\/jinf.2000.0772_RF45","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0140-6736(85)92819-3","article-title":"Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS","volume":"1","author":"Navin","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0772_RF46","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/archinte.1988.00380120121024","article-title":"Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person","volume":"148","author":"Raviglione","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1053\/jinf.2000.0772_RF47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00002030-199503000-00001","article-title":"Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?","volume":"9","author":"Koopmans","year":"1995","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0772_RF48","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(82)91355-1","article-title":"Adverse reactions to pyrimethamine-sulfadoxine","volume":"2","author":"Koch-Weser","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0772_RF49","first-page":"27","article-title":"Effectiveness of early therapy with corticosteroids in Stevens\u2013Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis","volume":"73","author":"Patterson","year":"1994","journal-title":"Ann Allergy"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445300907722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445300907722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:22:26Z","timestamp":1758986546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445300907722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0163445300907722"],"URL":"https:\/\/doi.org\/10.1053\/jinf.2000.0772","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2001,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twice-weekly Pyrimethamine\u2013sulfadoxine Effectively Prevents Pneumocystis carinii Pneumonia Relapse and Toxoplasmic Encephalitis in Patients with AIDS","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jinf.2000.0772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}